Abstract
Sef is a transmembrane protein inhibiting FGF signaling. To determine the correlation of Sef with human diseases, Sef expression patterns were observed in cell lines and human cancer tissues. Western blot using anti-hSef antibodies showed that hSef, when expressed in Cos7 cells gave a molecular mass of 100 KD as compared with 80 KD in an in vitro translation assay suggesting occurrence of glycosylation at the potential N-linked glycosylation sites in the extracellular domain. Northern blot showed that hSef was mainly expressed in human kidney and testis. RT-PCR analysis showed a widely spread expression pattern in several cell lines. Immunohistochemical analysis revealed a high expression level of hSef in kidney, testis, and the corresponding carcinoma tissues. Results demonstrated that Sef might be up-regulated in the cancer tissues suggesting a possible role of Sef in pathophysiology of human diseases.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Ella P., Inbal Z., Ariel S., Ifat S., Michael T., Igor B., Dawid Y.-A., Dina R., Alternative splicing generates an isoform of the human Sef gene with altered subcellular localization and specificity, Proc. Natl. Acad. Sci., 2004, 101(5): 1229–1234
Furthauer M., Lin W., Ang S.-L., Thisse B., Thisse C., Sef is a feedback-induced antagonist of Ras/MAPK-mediated FGF signaling, Nat. Cell Biol., 2002, 4(2): 170–174
Hill C.-S. and Treisman R., Transcriptional regulation by extracellular signals: mechanisms and specificity, Cell, 1995, 80(2): 199–211
Hogan B.-L., Morphogenesis, Cell, 1999, 96(2): 225–233
Hunter T., Signaling-2000 and beyond, Cell, 2000, 100(1): 113–127
Klein S., Roghani M., Rifkin D.-B., Fibroblast growth factors as angiogenesis factors: new insights into their mechanism of action, EXS, 1997, 79: 159–192
Kovalenko D., Yang X., Nadeau R.-J., Harkins L.-K., Friesel R., Sef inhibits fibroblast growth factor signaling by inhibiting FGFR1 tyrosine phosphorylation and subsequent ERK activation, J. Biol. Chem., 2003, 278(16): 14087–14091
Lemmon M.-A., Schlessinger J., Regulation of signal transduction and signal diversity by receptor oligomerization. Trends Biochem. Sci., 1994, 19(11): 459–463
Lorenzi M.-V., Horii Y., Yamanaka R., Sakaguchi K., Miki T., FRAG1, a gene that potently activates fibroblast growth factor receptor by C-terminal fusion through chromosomal rearrangement, Proc. Natl. Acad. Sci. U.S.A., 1996, 93(17): 8956–8961
Tsang M., Friesel R., Kudoh T., Dawid I.-B., Identification of Sef, a novel modulator of FGF signaling, Nat. Cell Biol., 2002, 4(2): 165–169
Xiong S., Zhao Q., Rong Z., Huang G., Huang Y., Chen P., Zhang S., Liu L., Chang Z., hSef inhibits PC-12 cell differentiation by interfering with Ras-mitogen-activated protein kinase MAPK signaling, J. Biol. Chem., 2003, 278(50): 50273–50282
Yang R.-B., Ng C.-K., Wasserman S.-M., Komuves L.-G., Gerritsen M.-E., Topper J.N., A novel interleukin-17 receptor-like protein identified in human umbilical vein endothelial cells antagonizes basic fibroblast growth factor-induced signaling, J. Biol. Chem., 2003, 278(35): 33232–33238
Author information
Authors and Affiliations
Corresponding author
Additional information
__________
Translated from Chinese Journal of Biochemistry and Molecular Biology, 2005, 21 (2) [译自: 中国生物化学与分子生物学报, 2005,21(2)]
Rights and permissions
About this article
Cite this article
Huang, G., Xiong, S., Zhao, Q. et al. Expression of hSef in various human tissues and cell lines. Front. Biol. China 1, 104–109 (2006). https://doi.org/10.1007/s11515-006-0011-1
Issue Date:
DOI: https://doi.org/10.1007/s11515-006-0011-1